HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Susanne Schnittger Selected Research
Susanne Schnittger Research Topics
Disease
48
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2014 - 03/2002
24
Leukemia
01/2020 - 04/2002
16
Neoplasms (Cancer)
02/2016 - 03/2002
9
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017 - 04/2005
9
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
08/2014 - 03/2002
6
Acute Promyelocytic Leukemia
02/2018 - 01/2002
6
Residual Neoplasm
03/2014 - 06/2006
6
Chromosome Aberrations (Chromosome Abnormalities)
10/2010 - 04/2002
4
Eosinophilia
12/2015 - 06/2006
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2011 - 08/2003
3
Refractory Anemia
05/2013 - 06/2007
2
Splenomegaly
09/2015 - 12/2014
2
Systemic Mastocytosis
09/2015 - 10/2013
2
B-Cell Lymphoma (Lymphoma, B Cell)
12/2014 - 07/2010
2
Hematologic Neoplasms (Hematological Malignancy)
06/2013 - 03/2002
2
Thrombocytosis (Thrombocythemia)
05/2013 - 07/2012
2
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2013 - 05/2012
1
Disease Progression
10/2017
1
Lymphadenopathy
09/2015
1
Ascites
09/2015
1
primary familial and congenital Polycythemia
01/2014
1
Hypoxia (Hypoxemia)
01/2014
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2013
1
Mast-Cell Leukemia (Leukemia, Mast Cell)
10/2013
1
Anemia
07/2013
1
Schinzel-Giedion syndrome
01/2013
1
Primary Myelofibrosis (Myelosclerosis)
03/2011
1
Thrombosis (Thrombus)
03/2011
1
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2011
1
Glioma (Gliomas)
12/2010
1
Philadelphia Chromosome
10/2010
1
Multiple Myeloma
07/2010
1
Myocardial Infarction
12/2008
1
Hypereosinophilic Syndrome (Loeffler Endocarditis)
12/2008
1
Refractory Anemia with Excess of Blasts (RAEM)
06/2007
Drug/Important Bio-Agent (IBA)
9
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
12/2015 - 02/2003
9
Biological Products
IBA
09/2014 - 10/2003
6
Imatinib Mesylate (Gleevec)
FDA Link
09/2014 - 05/2006
6
Biomarkers (Surrogate Marker)
IBA
08/2014 - 06/2011
6
Nucleophosmin
IBA
09/2009 - 12/2005
5
Proteins (Proteins, Gene)
FDA Link
12/2014 - 08/2003
5
Messenger RNA (mRNA)
IBA
09/2014 - 10/2006
4
Hemoglobins (Hemoglobin)
IBA
09/2015 - 03/2011
4
Codon (Codons)
IBA
03/2014 - 03/2006
4
DNA (Deoxyribonucleic Acid)
IBA
12/2013 - 03/2002
4
Oligonucleotides
IBA
07/2010 - 08/2003
3
Tretinoin (Retinoic Acid)
FDA Link
Generic
02/2018 - 08/2003
3
Transcription Factors (Transcription Factor)
IBA
02/2016 - 08/2005
3
Janus Kinase 2
IBA
12/2014 - 07/2012
3
Antigens
IBA
05/2013 - 11/2006
3
Core Binding Factors (Core-Binding Factor)
IBA
07/2010 - 04/2005
3
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
12/2006 - 07/2003
2
Cytarabine (Cytosar-U)
FDA Link
Generic
02/2018 - 06/2006
2
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
12/2015 - 06/2013
2
CCAAT-Enhancer-Binding Proteins
IBA
10/2013 - 05/2012
2
MicroRNAs (MicroRNA)
IBA
10/2013 - 03/2008
2
Phosphotransferases (Kinase)
IBA
10/2010 - 02/2006
2
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
IBA
04/2005 - 01/2002
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
02/2005 - 11/2002
2
Monoclonal Antibodies
IBA
11/2004 - 01/2004
1
dactolisib
IBA
01/2020
1
Phosphatidylinositol 3-Kinases (PI 3 Kinase)
IBA
01/2020
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2020
1
TOR Serine-Threonine Kinases
IBA
01/2020
1
Anthracyclines
IBA
02/2018
1
Azacitidine (5 Azacytidine)
FDA Link
10/2017
1
Dasatinib (BMS 354825)
FDA Link
10/2017
1
Tryptases (Tryptase)
IBA
09/2015
1
Janus Kinase Inhibitors
IBA
12/2014
1
Oxygen (Dioxygen)
IBA
01/2014
1
2,3-Diphosphoglycerate (2,3 Bisphosphoglycerate)
IBA
01/2014
1
Tyrosine Kinase Inhibitors
IBA
01/2014
1
Erythropoietin
FDA Link
01/2014
1
Cyclin D1
IBA
12/2013
1
Protein Kinase C
IBA
01/2013
1
MDS1 and EVI1 Complex Locus Protein
IBA
12/2012
1
Differentiation Antigens
IBA
09/2012
1
CD8 Antigens
IBA
05/2012
1
Core Binding Factor Alpha 2 Subunit
IBA
12/2011
1
Cyclin-Dependent Kinase Inhibitor p27
IBA
06/2011
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
12/2010
1
Enzymes
IBA
12/2010
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
07/2010
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2010
1
MDS 11
IBA
10/2009
1
Nuclear Proteins (Protein, Nuclear)
IBA
05/2008
1
Nucleotides
IBA
03/2008
1
Arginine (L-Arginine)
FDA Link
07/2007
1
Hydroxyurea (Hydrea)
FDA Link
Generic
05/2007
Therapy/Procedure
29
Therapeutics
02/2018 - 03/2002
9
Stem Cell Transplantation
03/2014 - 05/2006
6
Drug Therapy (Chemotherapy)
02/2018 - 04/2002
3
Hematopoietic Stem Cell Transplantation
02/2011 - 03/2010
2
Transplantation
08/2011 - 08/2005
2
Time-to-Treatment
10/2010 - 09/2010
2
Induction Chemotherapy
01/2009 - 07/2006
2
Radiotherapy
04/2002 - 03/2002
1
Aftercare (After-Treatment)
02/2014
1
Homologous Transplantation
04/2013
1
Molecular Targeted Therapy
05/2008